COMENTARIOS BIBLIOGRÁFICOS
Barra lateral del artículo
Contenido principal del artículo
Resumen
-
Detalles del artículo
Derechos de autor: Actualizaciones en Osteología es la revista oficial de la Asociación Argentina de Osteología y Metabolismo Mineral (AAOMM) que posee los derechos de autor de todo el material publicado en dicha revista.
Citas
Sánchez A, Puche R, Zeni S, et al. Papel del calcio y de la vitamina D en la salud ósea. Rev Esp Enf Metab Oseas 2002; 11:201-17 (Parte I). 2003; 12: 14-29 (Parte II).
O’Connell MB, Madden DM, Murray AM, Heaney RP, Kerzner LJ. Effects of proton pump inhibitors on calcium carbonate
absorption in women: a randomized crossover trial. Am J Med 2005; 118: 778-81.
Clarke BL, Amin S. Commentary on Yang et al, 2006. Nature Clin Pract Endocrinol Metab 2007; 3: 565.
Yang Y, Lewis JD, Epstein S, Metz DC. Long-term proton pump inhibitor therapy and risk of hip fracture. JAMA 296: 2947-53,
Vestergaard P, Rejnmark L, Mosekilde L. Proton pump inhibitors, histamine H2 receptor antagonists, and other antacid medications and the risk of fracture. Calcif Tissue Int 2006; 79: 76-83.
Grisso JA, Kelsey JL, O’Brien LA, et al. Risk factors for hip fracture in men. Hip Fracture Study Group. Am J Epidemiol 1997;145: 786-93.
Targownik LE, Lix LM, Metge CJ, Prior HJ, Leung S, Leslie WD. Use of proton pump inhibitors and risk of osteoporosisrelated fractures. Can Med Ass J 2008;179: 319-26.
Mizunashi K, Furukawa Y, Katano K, et al. Effect of omeprazole, an inhibitor of H+,K+- ATPase, on bone resorption in humans. Calcif Tissue Int 1993; 53: 21-5.
Wilcox CM, Allison J, Benzuly K, et al. Consensus development conference on the use of nonsteroidal anti-inflammatory agents,
including cyclooxygenase-2 enzyme inhibitors and aspirin. Clin Gastroenterol Hepatol 2006; 4: 1082-9.
Jacobson BC, Ferris TG, Shea TL, et al. Who is using chronic acid suppression therapy and why? Am J Gastroenterol 2003; 98:
-8.
Pillans PI, Kubler PA, Radford JM, Overland V. Concordance between use of proton pump inhibitors and prescribing guidelines.
Med J Aust 2000; 172: 16-8.
Inadomi JM, Jamal R, Murata GH, et al. Step-down management of gastroesophageal reflux disease. Gastroenterology 2001;
: 1095-100.
Bjornsson E, Abrahamsson H, Simren M, et al. Discontinuation of proton pump inhibitors in patients on long-term therapy: a double-blind, placebo-controlled trial. Aliment Pharmacol Ther 2006; 24: 945-54.
Richards JB, Goltzman B. Proton pump inhibitors: balancing the benefits and potential fracture risks (Editorial). Can Med Ass J
; 179: 36-7.